These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 5940693)

  • 1. Urinary hydroxyproline and calcium metabolism in patients with cancer.
    Bonadonna G; Merlino MJ; Myers WP; Sonenberg M
    N Engl J Med; 1966 Aug; 275(6):298-305. PubMed ID: 5940693
    [No Abstract]   [Full Text] [Related]  

  • 2. Disturbances of calcium metabolism in the cancer patient.
    Pearson OH
    Proc Natl Cancer Conf; 1964; 5():445-50. PubMed ID: 5856173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium metabolism in breast cancer.
    Coombes RC; Powles TJ; Joplin DG
    Proc R Soc Med; 1977 Mar; 70(3):195-9. PubMed ID: 870901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
    Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
    Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium and neoplasms. Effect of daunomycin. Hypercalcemia in neoplasms].
    Bossa R; Galatulas I
    G Ital Chemioter; 1975; 22(1-2):55-62. PubMed ID: 1235354
    [No Abstract]   [Full Text] [Related]  

  • 8. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
    Polico C; Nascimben O; Maccari F; Fazzin G
    Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hydrochlorothiazide on various parameters of calcium and phosphate metabolism in patients with increased bone resorption caused by malignant metastases to the skeleton].
    Gasińska T; Rozek-Lesiak K; Harbut-Gryłka A
    Pol Tyg Lek; 1979 Sep; 34(38):1499-502. PubMed ID: 503956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
    Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
    Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary hydroxyproline excretion in patients with breast cancer.
    Cuschieri A; Felgate R
    Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876
    [No Abstract]   [Full Text] [Related]  

  • 14. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB; Palmieri GM; Neely CL; McDonald MW
    Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant neoplasms and calcium metabolism (a review of the literature)].
    Kashulina AP; Tereshchenko IP
    Patol Fiziol Eksp Ter; 1973; 17(5):84-8. PubMed ID: 4789470
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort.
    Magnuson SK; Booth R; Porter S; Gorski JP
    J Bone Miner Res; 1997 Feb; 12(2):200-9. PubMed ID: 9041051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
    Sumner DS; Baum M; Parsons V; Edwards MH
    Br J Surg; 1973 Apr; 60(4):306. PubMed ID: 4700234
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
    Powles TJ
    Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase of urinary elimination of hydroxyproline in osteolytic processes].
    RUBEGNI M; RAVENNI G; DEL GIOVANE L
    Boll Soc Ital Biol Sper; 1962 Sep; 38():877-8. PubMed ID: 13982943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.